Olumuyiwa Bamgbade is an accomplished health care leader with a strong focus on value-based health care delivery. A specialist physician with extensive training across Nigeria, the United Kingdom, the United States, and South Korea, Dr. Bamgbade brings a global perspective to clinical practice and health systems innovation.
He serves as an adjunct professor at academic institutions across Africa, Europe, and North America and has published 45 peer-reviewed scientific papers in PubMed-indexed journals. His global research collaborations span more than 20 countries, including Nigeria, Australia, Iran, Mozambique, Rwanda, Kenya, Armenia, South Africa, the U.K., China, Ethiopia, and the U.S.
Dr. Bamgbade is the director of Salem Pain Clinic in Surrey, British Columbia, Canada—a specialist and research-focused clinic. His work at the clinic centers on pain management, health equity, injury rehabilitation, neuropathy, insomnia, societal safety, substance misuse, medical sociology, public health, medicolegal science, and perioperative care.
Research misconduct deserves scrutiny. But scrutiny should not become spectacle. The landmark 1980s case of U.S. cardiology researcher John Darsee remains a defining example. Auditors found extensive data fabrication, and federal sanctions reached beyond institutional leadership, forcing science research to confront supervision, authorship, and institutional accountability. The lesson was not simply that one researcher failed. The institution and research system also need safeguards.
Four decades later, the Retraction Watch leaderboard of …
Read more…
Research integrity and accountability lessons from 2026
Research retractions are not all misconduct, and a leaderboard is not a verdict. The Retraction Watch database leaderboard, updated August 2026, shows researchers with dozens or hundreds of retractions but also cautions that its ranking is unofficial and shaped by what can be verified. Its treatment of the landmark 1980s case involving a Harvard University cardiologist illustrates why raw counts require context. Nonetheless, these cases expose recurring vulnerabilities that every …
Read more…
7 lessons from research retractions about integrity
Testosterone is one of the most discussed and misunderstood tools in modern men’s health. On one hand, it is portrayed as a remedy for aging. On the other, its legitimate clinical value is frequently downplayed. The evidence suggests a more nuanced view: Testosterone replacement can be life-changing for appropriately diagnosed hypogonadism, while many broader benefits remain evolving or indirect.
The well-known benefits are in hormonal and sexual health. For men with …
Read more…
Testosterone therapy for men requires precision care
Men’s health has often been limited to discussions about prostate, erectile dysfunction, and testosterone levels. This perspective is narrow. A more comprehensive model connects metabolic health, hormones, sexual function, mental well-being, and everyday self-care. These elements are interconnected and frequently influence one another.
Glucagon-like peptide-1 (GLP-1) therapeutics have accelerated this shift. Medications like semaglutide and tirzepatide have transformed obesity treatment from a focus on willpower to one based on biology, chronic …
Read more…
The future of men’s health is not another prescription
Pharmaceutical research and development (R&D) has never lacked scientific ambition. The more challenging issue is transforming good science into programs that operate efficiently, address the right questions, and ultimately enhance patient care. This necessitates a different type of R&D leader.
Traditional research leadership often emphasizes depth in a scientific discipline. While that expertise is crucial, modern drug development is no longer a series of isolated scientific tasks; it is a comprehensive …
Read more…
3 realms every drug development leader must bridge
Clinical research is typically managed one protocol at a time, with each study having its own budget, timeline, team, recruitment target, and publication plan. While this structure is essential, it can obscure a larger truth. Research organizations do not merely manage projects; they manage portfolios of strategic bets.
Every trial utilizes limited resources. Investigator time, research staff, patient access, data infrastructure, funding, laboratory capacity, and organizational attention cannot be allocated everywhere …
Read more…
A clinical research portfolio is a set of strategic bets
Frontline clinicians work in a paradox. We care for others at their most vulnerable moments, yet we struggle to admit our own vulnerability. We recognize pain in patients, but we may miss it in the colleague working with us. We respond quickly to patients’ clinical deterioration, but we ignore our emotional deterioration until it becomes dangerous.
Frontline clinician suicide is not only an individual tragedy. It is also a workplace warning …
Read more…
Clinician peer support is a patient safety issue
A publication in Nature in April 2026 reports that N-desethyl-fluornitrazene (DFNZ), a modified nitazene and µ-opioid receptor (MOR) superagonist, produced potent analgesia in rodents with less respiratory depression, weaker dopamine-linked reward signaling, lower withdrawal burden, and no clear tolerance or MOR downregulation. The study challenges the usual assumption that very high MOR efficacy must inevitably produce the full adverse-effect profile seen with conventional opioids. Opioid pharmacology has long been …
Read more…
How the opioid superagonist DFNZ challenges pain medicine
The internet has made patients more informed. It has also made some patients more misled. A small but growing body of medical commentary has used the provocative label “internet-derived information obstruction treatment (IDIOT)” syndrome to describe what happens when people trust online medical content so blindly that they delay care, stop treatment, self-medicate, or resist sound clinical judgment. The term appears in published reviews and commentaries, but it is not …
Read more…
How IDIOT syndrome threatens value-based health care
Health care initiatives will not succeed on policy language alone. They must work in patients’ daily lives. That means helping patients take medications correctly, monitor symptoms early, comply with treatment plans, recover safely after procedures, and stay engaged in long-term behavior change. Persuasive technologies are designed to help people adopt and keep using digital or other products. The best persuasive technologies for modern or value-based health care are not the …
Read more…
Using persuasive technologies in value-based health care
Many doctors hear “the United Nations Sustainable Development Goals” and assume the subject belongs to diplomats, ministers, and development agencies. It does not. Doctors advance the Sustainable Development Goals every day, often without naming them. The United Nations’ 2030 Agenda includes 17 goals designed as an integrated framework for human well-being, equity, prosperity, sustainability, and partnership. They are meant to work together, not in silos. That matters because health does …
Read more…
Medicine and the United Nations Sustainable Development Goals
People often say doctors should perform like flight or rescue teams. The comparison sounds flattering. It is also incomplete. Pilots, ship captains, firefighters, coastguards, and rescue teams all work in high-stakes environments. They train hard. They lead under pressure. They make critical decisions with lives at risk. Medicine shares that gravity. But the real-world challenge of clinical medicine is often more complex, less controlled, and more exposed to uncertainties than …
Read more…
Why clinical medicine is harder than flying a plane
Hindsight flatters certainty. Clinical medicine does not. After a bad outcome, everyone becomes smarter. The diagnosis looks obvious. The warning signs seem bright. The missed clue appears unforgivable. In the calm of retrospective review, people ask, “How could the doctor not have seen it?” That question sounds fair. Often, it is not. Real-world medicine does not happen in hindsight. It happens in the presence of noise, time pressure, incomplete information, …
Read more…
How hindsight bias distorts clinical medicine
Defensive medicine grows where fear rules. Value-based health care grows where judgment, trust, and outcomes matter. That is the clash now facing many doctors. On paper, health systems say they want high-value care, better outcomes, lower waste, and patient-centered decisions. In real life, many doctors practice in an environment shaped by needless complaints, crushing legal defense costs, underfunded services, regulator overreach, and instant reputational damage through online and social media. …
Read more…
The clash between defensive medicine and value-based health care
Every difficult patient is not dangerous. But every high-conflict encounter carries risk. Doctors like to think clinical skill will protect them: It will not. In modern practice, a physician can make a sound decision, communicate it poorly, and still walk into a complaint, a licensing problem, a lawsuit, or public reputational damage. That risk becomes even sharper in the care of chronic pain, substance misuse, insurance-driven visits, and patients whose …
Read more…
How to manage a difficult patient and survive a high-conflict encounter
Many physicians see fee schedules, payment rates, billing codes, and pension negotiations as administrative work best left to a few elected representatives, policy experts, or government staff. However, these physician payment tariff negotiations shape how care is delivered, how practices remain viable, how new services are recognized, and how the profession sustains itself over time. They involve fee codes, billing rules, payment rates, service descriptions, pensions, compensation models, and allocation …
Read more…
Why physicians must lead payment tariff negotiations
A false accusation or unfair allegation can destroy a doctor long before any court delivers a verdict. That is the part the public rarely sees. A charge alone can shatter a medical career. It can trigger suspension, isolation, gossip, media exposure, loss of referrals, financial collapse, and permanent reputational injury. In many cases, the accusation becomes the punishment. The acquittal verdict arrives later. By then, the damage is already carved …
Read more…
Why false accusations against doctors destroy careers
Health care works best when it solves real problems in real lives. That is why recent research on ketamine therapy for chronic pain deserves attention. The peer-reviewed study looked at 20 adults living with chronic pain who also struggled with substance misuse. The results suggest that carefully designed pain treatment may help more than pain alone. It may also improve mood and support recovery from substance misuse. In a …
Read more…
Ketamine therapy for chronic pain and substance misuse
Physicians hold one of the most essential and sacred trusts in every society: the care of human life. Yet across many developed nations, this trust is undermined by a growing culture of suspicion, litigation, sensationalism, and retaliation. When unethical malpractice lawyers hunt for profit, unfair regulators overreach with bureaucratic zeal, unprofessional journalists publish half-truths for headlines, or disgruntled patients weaponize complaints, the damage goes far beyond the doctor’s reputation. The …
Read more…
How undermining physicians harms society
In 2025, Canada’s universal health care or Medicare system confronted a stark wake-up call. Many high-visibility service disruptions exposed the health care delivery model’s fragility and stress points. There were emergency room (ER) closures and specialty service interruptions.
In British Columbia, many hospitals repeatedly and increasingly closed their ERs for hours or days due to staffing shortages. The hospitals in large cities like Delta and Mission had multiple separate ER shutdowns. …
Read more…
Canada’s 2025 health care crisis explained
